FTSE 100 heads for fourth session of gains

Credit: REUTERS/DYLAN MARTINEZ

London's FTSE 100 held firm at a near one-month high on Thursday as gains in AstraZeneca after a 2019 target upgrade countered losses in Royal Bank of Scotland following a weak third-quarter update, while midcaps outperformed as sterling rose.

For a live blog on European stocks, type LIVE/ in an Eikon news window

FTSE 100 up 0.1%, FTSE 250 up 0.2%

AstraZeneca biggest boost to main index

RBS slides after reporting Q3 loss

Oct 24 (Reuters) - London's FTSE 100 held firm at a near one-month high on Thursday as gains in AstraZeneca after a 2019 target upgrade countered losses in Royal Bank of Scotland following a weak third-quarter update, while midcaps outperformed as sterling rose.

The blue-chip index .FTSE inched up by 0.1% at 0708 GMT, while the FTSE 250 index .FTMC gained 0.2%.

AstraZeneca AZN.L added 2.3% after the pharmaceutical giant raised its annual product sales forecast for the second time this year, thanks in part to strong demand for new cancer treatments.

On the other end of the spectrum was Royal Bank of Scotland RBS.L that skidded 3% as it swung to a third-quarter loss due to a fresh 900 million pound provision to settle mis-selling claims in Britain's biggest consumer banking scandal.

(Reporting by Muvija M and Shashwat Awasthi in Bengaluru; Editing by Arun Koyyur)

((muvija.m@tr.com; within UK +44 20 7542 1810, outside UK +91 80 6749 3638;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More